The self-medication hypothesis and psychostimulant treatment of cocaine dependence: An update

American Journal on Addictions

Volumn 23, Issue 2, 2014, Pages 189-193

  Mariani, John J ^a,b   Khantzian, Edward J ^c,d   Levin, Frances R ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Tewksbury Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADULT; CASE REPORT; COCAINE-RELATED DISORDERS; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGY; SELF MEDICATION;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; SELF MEDICATION;

EID: 84893850723     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12086.x     Document Type: Review

References (45)

1. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Office of Applied Studies; 2011. Publication No. SMA 11-4658.
2. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64: 566-576. (Pubitemid 46718289)
3. Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008; 165: 179-187. (Pubitemid 351704516)
4. Khantzian EJ., An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am J Psychiatry. 1983; 140: 784-785. (Pubitemid 13094151)
5. Khantzian EJ, Gawin F, Kleber HD, et al. Methylphenidate (Ritalin) treatment of cocaine dependence-A preliminary report. J Subst Abuse Treat. 1984; 1: 107-112. (Pubitemid 14009508)
6. Mariani JJ, Pavlicova M, Bisaga A, et al. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: A randomized controlled trial. Biol Psychiatry. 2012; 72: 950-956.
7. White FJ, Kalivas PW., Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998; 51: 141-153. (Pubitemid 28353762)
8. Amato L, Davoli M, Perucci CA, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005; 28: 321-329. (Pubitemid 40733141)
9. Berrettini WH, Lerman CE., Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry. 2005; 162: 1441-1451. (Pubitemid 41105558)
10. Schubiner H, Saules KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002; 10: 286-294. (Pubitemid 34919937)
11. Levin FR, Evans SM, Brooks DJ, et al. Treatment of methadone-maintained patients with adult ADHD: Double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend. 2006; 81: 137-148. (Pubitemid 41821797)
12. Grabowski J, Roache JD, Schmitz JM, et al. Replacement medication for cocaine dependence: Methylphenidate. J Clin Psychopharmacol. 1997; 17: 485-488. (Pubitemid 28389189)
13. Grabowski J, Rhoades H, Schmitz J, et al. Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial. J Clin Psychopharmacol. 2001; 21: 522-526. (Pubitemid 32937435)
14. Shearer J, Wodak A, van Beek I, et al. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction (Abingdon, England). 2003; 98: 1137-1141. (Pubitemid 36936500)
15. Dackis CA, Kampman KM, Lynch KG, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005; 30: 205-211. (Pubitemid 40024415)
16. Poling J, Oliveto A, Petry N, et al. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006; 63: 219-228. (Pubitemid 43213884)
17. Anderson AL, Reid MS, Li SH, et al. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009; 104: 133-139.
18. Mooney ME, Herin DV, Schmitz JM, et al. Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2009; 101: 34-41.
19. Grabowski J, Rhoades H, Stotts A, et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: Two double-blind randomized clinical trials. Neuropsychopharmacology. 2004; 29: 969-981. (Pubitemid 38526797)
20. Schmitz JM, Rathnayaka N, Green CE, et al. Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: A preliminary investigation. Front Psychiatry. 2012; 3: 1-6.
21. Castells X, Casas M, Perez-Mana C, et al. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev. 2010; CD007380.
22. Mariani JJ, Levin FR., Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am. 2012; 35: 425-439.
23. Chiodo KA, Lack CM, Roberts DC., Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology (Berl). 2008; 200: 465-473.
24. Negus SS, Mello NK., Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl). 2003; 167: 324-332. (Pubitemid 36712980)
25. Czoty PW, Martelle JL, Nader MA., Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology (Berl). 2010; 209: 375-382.
26. Martinez D, Carpenter KM, Liu F, et al. Imaging dopamine transmission in cocaine dependence: Link between neurochemistry and response to treatment. Am J Psychiatry. 2011; 168: 634-641.
27. Volkow ND, Wang GJ, Tomasi D, et al. Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers. PLoS ONE. 2010; 5: 1-9.
28. Rush CR, Stoops WW, Hays LR., Cocaine effects during D-amphetamine maintenance: A human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend. 2009; 99: 261-271.
29. Rush CR, Stoops WW, Sevak RJ, et al. Cocaine choice in humans during D-amphetamine maintenance. J Clin Psychopharmacol. 2010; 30: 152-159.
30. Katusic SK, Barbaresi WJ, Colligan RC, et al. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: A population-based, birth cohort study. J Child Adolesc Psychopharmacol. 2005; 15: 764-776. (Pubitemid 41567148)
31. Wilens TE., Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry. 2004; 65: 38-45.
32. Wender P., Psychiatric Aspects of Minimal Brain Dysfunction in Adults. New York, NY: Grune & Stratton; 1979.
33. Huessy R, Cohen S, Blair C., Clinical explorations in adult minimal dysfunction. In:, Bellak L, ed. Psychiatric aspects of minimal brain dysfunction in adults. New York, NY: Grune & Stratton; 1979.
34. Yang LK, Shang CY, Gau SS., Psychiatric comorbidities in adolescents with attention-deficit hyperactivity disorder and their siblings. Can J Psychiatry. 2011; 56: 281-292.
35. Cumyn L, French L, Hechtman L., Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2009; 54: 673-683.
36. McIntyre RS, Kennedy SH, Soczynska JK, et al. Attention-deficit/ hyperactivity disorder in adults with bipolar disorder or major depressive disorder: Results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry. 2010; 12: 1-6.
37. Khantzian EJ., The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry. 1997; 4: 231-244. (Pubitemid 27086599)
38. Khantzian EJ., The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry. 1985; 142: 1259-1264. (Pubitemid 16216560)
39. Khantzian EJ., The self-medication hypothesis revisited: The dually diagnosed patient. Prim Psychiatry. 2003; 10: 47-54. (Pubitemid 37283597)
40. Arendt M, Rosenberg R, Fjordback L, et al. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol Med. 2007; 37: 935-945. (Pubitemid 46993594)
41. Segarra R, Zabala A, Eguiluz JI, et al. Cognitive performance and smoking in first-episode psychosis: The self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci. 2011; 261: 241-250.
42. Swendsen JD, Tennen H, Carney MA, et al. Mood and alcohol consumption: An experience sampling test of the self-medication hypothesis. J Abnorm Psychol. 2000; 109: 198-204. (Pubitemid 30616916)
43. Hall DH, Queener JE., Self-medication hypothesis of substance use: Testing Khantzian's updated theory. J Psychoactive Drugs. 2007; 39: 151-158. (Pubitemid 47105697)
44. Carrigan MH, Randall CL., Self-medication in social phobia: A review of the alcohol literature. Addict Behav. 2003; 28: 269-284. (Pubitemid 36164859)
45. Chambers RA., A nicotine challenge to the self-medication hypothesis in a neurodevelopmental animal model of schizophrenia. J Dual Diagn. 2009; 5: 139-148.